Penumbra
PEN
#1754
Rank
โ‚น1.019 T
Marketcap
โ‚น26,039
Share price
-1.69%
Change (1 day)
27.69%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Revenue for Penumbra (PEN)

Revenue in 2025 (TTM): โ‚น115.37 Billion

According to Penumbra's latest financial reports the company's current revenue (TTM ) is โ‚น119.82 Billion. In 2024 the company made a revenue of โ‚น102.48 Billion an increase over the revenue in the year 2023 that were of โ‚น88.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Penumbra from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น115.37 B12.58%
2024 โ‚น102.48 B16.3%
2023 โ‚น88.12 B25.71%
2022 โ‚น70.10 B25.98%
2021 โ‚น55.64 B35.77%
2020 โ‚น40.98 B4.99%
2019 โ‚น39.03 B25.47%
2018 โ‚น31.11 B45.99%
2017 โ‚น21.31 B19.1%
2016 โ‚น17.89 B44.69%
2015 โ‚น12.36 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Inari Medical
NARI
โ‚น51.61 B-56.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merit Medical
MMSI
โ‚น132.70 B 10.75%๐Ÿ‡บ๐Ÿ‡ธ USA